 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, February 15, 2001, 21(4):1334-1339
The Untranslated Region of µ-Opioid Receptor mRNA Contributes to Reduced Opioid Sensitivity in CXBK Mice
Kazutaka Ikeda1, 2, Toru Kobayashi3, Tomio Ichikawa3, Toshiro Kumanishi3, Hiroaki Niki1, and Ryoji Yano2 Laboratories for 1 Neurobiology of Emotion and 2 Cellular Information Processing, Brain Science Institute, RIKEN, Wako, Saitama 351-0198, Japan, and 3 Department of Molecular Neuropathology, Brain Research Institute, Niigata University, Asahimachi, Niigata 951-8585, Japan
It is well known that there are individual differences in a sensitivity to analgesics. Several lines of evidence have suggested that the level of opioid-induced analgesia is dependent on the level of expression of the µ-opioid receptor (µ-OR). However, the molecular mechanisms underlying the diversity of the level of the opioid receptor and the opioid sensitivity among individuals remain to be elucidated. In the present study, we analyzed the opioid-receptor genes of CXBK recombinant-inbred mice, which show reduced sensitivity to opioids. Northern blotting, nucleotide sequencing, and in situ hybridization histochemical analyses demonstrated that CXBK mice possessed µ-OR mRNA with a normal coding region but an abnormally long untranslated region (UTR). In addition, the µ-OR mRNA level in CXBK mice was less than in the control mice. Next, we produced littermate mice that had inherited two copies of the wild-type µ-OR gene, had inherited two copies of the CXBK µ-OR gene, and had inherited both copies of the µ-OR genes. In these mice, inheritance of the CXBK µ-OR gene was well correlated with less µ-OR mRNA and reduced opioid effects on nociception and locomotor activity. We conclude that the CXBK µ-OR gene is responsible for the CXBK phenotypes. Because UTR differences are known to affect the level of the corresponding mRNA and protein and because UTRs are more divergent among individuals than coding regions, the present findings suggest that opioid sensitivity may vary, depending on different µ-OR levels attributable to divergent UTR of µ-OR mRNA.
Key words: CXBK mouse; µ-opioid receptor; UTR; individual difference; analgesia; morphine
Copyright © 2001 Society for Neuroscience 0270-6474/01/2141334-06$05.00/0
This article has been cited by other articles:
Q. Wu, P.-Y. Law, L.-N. Wei, and H. H. Loh
Post-transcriptional regulation of mouse {micro} opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b
FASEB J, December 1, 2008; 22(12): 4085 - 4095.
[Abstract] [Full Text] [PDF]
Q. Wu, C. K. Hwang, S. Yao, P.-Y. Law, H. H. Loh, and L.-N. Wei
A Major Species of Mouse {micro}-opioid Receptor mRNA and Its Promoter-Dependent Functional Polyadenylation Signal
Mol. Pharmacol., August 1, 2005; 68(2): 279 - 285.
[Abstract] [Full Text] [PDF]
H. S. Choi, C. K. Hwang, C. S. Kim, K. Y. Song, P.-Y. Law, L.-N. Wei, and H. H. Loh
Transcriptional Regulation of Mouse {micro} Opioid Receptor Gene: Sp3 Isoforms (M1, M2) Function as Repressors in Neuronal Cells to Regulate the {micro} Opioid Receptor Gene
Mol. Pharmacol., May 1, 2005; 67(5): 1674 - 1683.
[Abstract] [Full Text] [PDF]
P.-W. Lee, S. Wu, and Y.-M. Lee
Differential Expression of {micro}-Opioid Receptor Gene in CXBK and B6 Mice by Sp1
Mol. Pharmacol., December 1, 2004; 66(6): 1580 - 1584.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|